Retrospective study on the safety of COVID-19 vaccination in myasthenia gravis.

Alejandra Urra PincheiraSara AlnajjarHans KatzbergCarolina Barnett-TapiaLubna DaniyalRitesh RohanVera Bril

Published in: Muscle & nerve (2022)

COVID-19 vaccinations were well tolerated in MG patients and were not associated with worsening severity of their MG. The prevalence of vaccine-related adverse reactions was the same as in the general population.

Keyphrases

coronavirus disease
sars cov
myasthenia gravis
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
risk factors
peritoneal dialysis
emergency department
patient reported outcomes
adverse drug